Clinical Trial Update: A Study to Evaluate the Dose Response Based on the Efficacy, Safety and Tolerability of Bimekizumab in Subjects With Active Psoriatic Arthritis Which is a Type of Inflammatory Arthritis [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating dose response, efficacy, safety, and tolerability of bimekizumab in active psoriatic arthritis; study completed with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Drugs mentioned

• Bimekizumab (bimekizumab)

Snippet

Sponsor: UCB Biopharma S.P.R.L. | Conditions: Psoriatic Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2020-11-25